Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Navigation/Suche

• Forscher*innen.
• Institutionen.
• Projekte.
• Publikationen.
• Partner.
• Geldgeber.
• Ausstattung.
• Knowhow.
• Forschungsfelder.

Publikationen

Suchbegriffe: CHOLANGIOCARCINOMA, . Treffer: 54

2025

Skok, K; Stift, J; Schirmacher, P; Kashofer, K; Stauber, R; Ranković, B; Lackner, K Molecular Landscape and Treatment Paradigms of Hepatocellular and Cholangiocarcinoma: A Multinational Review.
Z Gastroenterol. 2025; Doi: 10.1055/a-2548-0108
Web of Science PubMed FullText FullText_MUG

 

2024

Albrecht, T; Rossberg, A; Rose, F; Breuhahn, K; Baumann, EM; Tóth, M; Brinkmann, F; Charbel, A; Vogel, MN; Köhler, B; Mehrabi, A; Büchler, MW; Singer, S; Solass, W; Straub, B; Schirmacher, P; Roessler, S; Goeppert, B Combined analysis of albumin in situ hybridisation and C reactive protein immunohistochemistry for the diagnosis of intrahepatic cholangiocarcinoma: towards a molecular classification paradigm.
J Clin Pathol. 2024; Doi: 10.1136/jcp-2024-209429 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Leonhardi, J; Sabanov, A; Höhn, AK; Sucher, R; Seehofer, D; Mehdorn, M; Schnarkowski, B; Ebel, S; Denecke, T; Meyer, HJ CT Texture Analysis of Perihilar Cholangiocarcinoma-Associations With Tumor Grading, Tumor Markers and Clinical Outcome.
Cancer Rep (Hoboken). 2024; 7(9): e2132 Doi: 10.1002/cnr2.2132 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2023

Schrom, S; Kleinegger, F; Anders, I; Hebesberger, T; Karner, C; Liesinger, L; Birner-Gruenberger, R; Renner, W; Pichler, M; Grillari, R; Aigelsreiter, A; Rinner, B MUG CCArly: A Novel Autologous 3D Cholangiocarcinoma Model Presents an Increased Angiogenic Potential.
Cancers (Basel). 2023; 15(6): 1757 Doi: 10.3390/cancers15061757 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Taghizadeh, H; Djanani, A; Eisterer, W; Gerger, A; Gruenberger, B; Gruenberger, T; Rumpold, H; Weiss, L; Winder, T; Wöll, E; Prager, GW Systemic treatment of patients with locally advanced or metastatic cholangiocarcinoma - an Austrian expert consensus statement.
Front Oncol. 2023; 13:1225154 Doi: 10.3389/fonc.2023.1225154 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2022

Benzing, C; Haiden, LM; Krenzien, F; Mieg, A; Wolfsberger, A; Atik, CF; Nevermann, N; Fehrenbach, U; Schöning, W; Schmelzle, M; Pratschke, J Textbook outcome after major hepatectomy for perihilar cholangiocarcinoma - definitions and influencing factors.
Langenbecks Arch Surg. 2022; 407(4): 1561-1573. Doi: 10.1007/s00423-022-02467-y [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Benzing, C; Schmelzle, M; Atik, CF; Krenzien, F; Mieg, A; Haiden, LM; Wolfsberger, A; Schöning, W; Fehrenbach, U; Pratschke, J Factors associated with failure to rescue after major hepatectomy for perihilar cholangiocarcinoma: A 15-year single-center experience.
Surgery. 2022; 171(4): 859-866. Doi: 10.1016/j.surg.2021.08.057
Web of Science PubMed FullText FullText_MUG

 

Seehofer, D; Sucher, R; Denecke, T [Resection and transplantation for hepatocellular carcinoma and intrahepatic cholangiocarcinoma].
Radiologe. 2022; 62(3): 210-218. Doi: 10.1007/s00117-021-00962-9
Web of Science PubMed FullText FullText_MUG

 

2021

Benzing, C; Krenzien, F; Mieg, A; Wolfsberger, A; Andreou, A; Nevermann, N; Pelzer, U; Fehrenbach, U; Haiden, LM; Öllinger, R; Schöning, W; Schmelzle, M; Pratschke, J A tailored approach in lymph node-positive perihilar cholangiocarcinoma.
Langenbecks Arch Surg. 2021; 406(5): 1499-1509. Doi: 10.1007/s00423-021-02154-4 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Hau, HM; Devantier, M; Jahn, N; Sucher, E; Rademacher, S; Seehofer, D; Sucher, R Impact of Body Mass Index on Tumor Recurrence in Patients Undergoing Liver Resection for Perihilar Cholangiocarcinoma (pCCA).
Cancers (Basel). 2021; 13(19): Doi: 10.3390/cancers13194772 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Sucher, R; Scheuermann, U; Seehofer, D Total Laparoscopic Resection of Hilar Cholangiocarcinoma Type 3b: Applying a Parachute Technique for Hepaticojejunostomy.
Ann Surg Oncol. 2021; 28(4):2030-2034 Doi: 10.1245/s10434-020-09175-1 (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Tóth, M; Wehling, L; Thiess, L; Rose, F; Schmitt, J; Weiler, SME; Sticht, C; De, La, Torre, C; Rausch, M; Albrecht, T; Grabe, N; Duwe, L; Andersen, JB; Köhler, BC; Springfeld, C; Mehrabi, A; Kulu, Y; Schirmacher, P; Roessler, S; Goeppert, B; Breuhahn, K Co-expression of YAP and TAZ associates with chromosomal instability in human cholangiocarcinoma.
BMC Cancer. 2021; 21(1): 1079 Doi: 10.1186/s12885-021-08794-5 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2020

Bekric, D; Neureiter, D; Ritter, M; Jakab, M; Gaisberger, M; Pichler, M; Kiesslich, T; Mayr, C Long Non-Coding RNAs in Biliary Tract Cancer-An Up-to-Date Review.
J Clin Med. 2020; 9(4): 1200 Doi: 10.3390/jcm9041200 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Cubero, FJ; Mohamed, MR; Woitok, MM; Zhao, G; Hatting, M; Nevzorova, YA; Chen, C; Haybaeck, J; de Bruin, A; Avila, MA; Boekschoten, MV; Davis, RJ; Trautwein, C Loss of c-Jun N-terminal Kinase 1 and 2 Function in Liver Epithelial Cells Triggers Biliary Hyperproliferation Resembling Cholangiocarcinoma.
Hepatol Commun. 2020; 4(6): 834-851. Doi: 10.1002/hep4.1495 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Gkika, E; Hawkins, MA; Grosu, AL; Brunner, TB The Evolving Role of Radiation Therapy in the Treatment of Biliary Tract Cancer.
Front Oncol. 2020; 10: 604387 Doi: 10.3389/fonc.2020.604387 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Hau, HM; Meyer, F; Jahn, N; Rademacher, S; Sucher, R; Seehofer, D Prognostic Relevance of the Eighth Edition of TNM Classification for Resected Perihilar Cholangiocarcinoma.
J Clin Med. 2020; 9(10): Doi: 10.3390/jcm9103152 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Reicher, A; Harris, AL; Prinz, F; Kiesslich, T; Wei, M; Öllinger, R; Rad, R; Pichler, M; Kwong, LN Generation of An Endogenous FGFR2-BICC1 Gene Fusion/58 Megabase Inversion Using Single-Plasmid CRISPR/Cas9 Editing in Biliary Cells.
Int J Mol Sci. 2020; 21(7): 2460 Doi: 10.3390/ijms21072460 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2019

Brunner, TB; Blanck, O; Lewitzki, V; Abbasi-Senger, N; Momm, F; Riesterer, O; Duma, MN; Wachter, S; Baus, W; Gerum, S; Guckenberger, M; Gkika, E Stereotactic body radiotherapy dose and its impact on local control and overall survival of patients for locally advanced intrahepatic and extrahepatic cholangiocarcinoma.
Radiother Oncol. 2019; 132:42-47 Doi: 10.1016/j.radonc.2018.11.015
Web of Science PubMed FullText FullText_MUG

 

Chuong, MD; Kaiser, A; Khan, F; Parikh, P; Ben-Josef, E; Crane, C; Brunner, T; Okumura, T; Schreuder, N; Bentzen, SM; Gutierrez, A; Mendez, Romero, A; Yoon, SM; Sharma, N; Kim, TH; Kishi, K; Moeslein, F; Hoffe, S; Schefter, T; Hanish, S; Scorsetti, M; Apisarnthanarax, S Consensus Report From the Miami Liver Proton Therapy Conference.
Front Oncol. 2019; 9:457 Doi: 10.3389/fonc.2019.00457 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Gkika, E; Strouthos, I; Kirste, S; Adebahr, S; Schultheiss, M; Bettinger, D; Fritsch, R; Brass, V; Maruschke, L; Neeff, HP; Lang, SA; Nestle, U; Grosu, AL; Brunner, TB Repeated SBRT for in- and out-of-field recurrences in the liver.
Strahlenther Onkol. 2019; 195(3):246-253 Doi: 10.1007/s00066-018-1385-0
Web of Science PubMed FullText FullText_MUG

 

Kleinegger, F; Hofer, E; Wodlej, C; Golob-Schwarzl, N; Birkl-Toeglhofer, AM; Stallinger, A; Petzold, J; Orlova, A; Krassnig, S; Reihs, R; Niedrist, T; Mangge, H; Park, YN; Thalhammer, M; Aigelsreiter, A; Lax, S; Garbers, C; Fickert, P; Rose-John, S; Moriggl, R; Rinner, B; Haybaeck, J Pharmacologic IL-6Rα inhibition in cholangiocarcinoma promotes cancer cell growth and survival.
Biochim Biophys Acta Mol Basis Dis. 2019; 1865(2):308-321 Doi: 10.1016/j.bbadis.2018.11.006 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2018

Beetz, O; Klein, M; Schrem, H; Gwiasda, J; Vondran, FWR; Oldhafer, F; Cammann, S; Klempnauer, J; Oldhafer, KJ; Kleine, M Relevant prognostic factors influencing outcome of patients after surgical resection of distal cholangiocarcinoma.
BMC Surg. 2018; 18(1): 56-56. Doi: 10.1186/s12893-018-0384-5 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Fehérvári, I; Piros, L; Végsõ, G; Máthé, Z [Liver transplantation in the treatment of hepatic tumors].
Magy Onkol. 2018; 62(1):26-28 [OPEN ACCESS]
PubMed

 

Jonas, S; Krenzien, F; Atanasov, G; Hau, HM; Gawlitza, M; Moche, M; Wiltberger, G; Pratschke, J; Schmelzle, M Hilar en bloc resection for hilar cholangiocarcinoma in patients with limited liver capacities-preserving parts of liver segment 4.
Eur Surg. 2018; 50(1): 22-29. Doi: 10.1007/s10353-017-0507-8 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Joosse, ME; Aardoom, MA; Kemos, P; Turner, D; Wilson, DC; Koletzko, S; Martin-de-Carpi, J; Fagerberg, UL; Spray, C; Tzivinikos, C; Sladek, M; Shaoul, R; Roma-Giannikou, E; Bronsky, J; Serban, DE; Ruemmele, FM; Garnier-Lengline, H; Veres, G; Hojsak, I; Kolho, KL; Davies, IH; Aloi, M; Lionetti, P; Hussey, S; Veereman, G; Braegger, CP; Trindade, E; Wewer, AV; Hauer, AC; de Vries, ACH; Sigall Boneh, R; Sarbagili Shabat, C; Levine, A; de Ridder, L; Paediatric IBD Porto group of ESPGHAN Malignancy and mortality in paediatric-onset inflammatory bowel disease: a 3-year prospective, multinational study from the paediatric IBD Porto group of ESPGHAN.
Aliment Pharmacol Ther. 2018; 48(5):523-537 Doi: 10.1111/apt.14893 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Juntermanns, B; Kaiser, GM; Orth, L; Reis, H; Jaradat, D; Sydor, S; Buechter, M; Kasper, S; Mathé, Z; Sotiropoulos, GC; Baba, HA; Canbay, A; Paul, A; Fingas, CD Comparison of the sixth and the seventh editions of the UICC classification for intrahepatic cholangiocarcinoma.
Eur J Med Res. 2018; 23(1):29-29 Doi: 10.1186/s40001-018-0329-6 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Matak, A; Lahiri, P; Ford, E; Pabst, D; Kashofer, K; Stellas, D; Thanos, D; Zatloukal, K Stochastic phenotype switching leads to intratumor heterogeneity in human liver cancer.
Hepatology. 2018; 68(3):933-948 Doi: 10.1002/hep.29679 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Tamandl, D; Ba-Ssalamah, A; Böhm, G; Emmanuel, K; Forstner, R; Függer, R; Henninger, B; Koch, O; Kölblinger, C; Mischinger, HJ; Schima, W; Schöllnast, H; Stättner, S; Kaczirek, K Austrian consensus guidelines on imaging requirements prior to hepatic surgery and during follow-up in patients with malignant hepatic lesions.
Wien Klin Wochenschr. 2018; 130(21-22):665-672 Doi: 10.1007/s00508-018-1387-z [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2017

Aabakken, L; Karlsen, TH; Albert, J; Arvanitakis, M; Chazouilleres, O; Dumonceau, JM; Färkkilä, M; Fickert, P; Hirschfield, GM; Laghi, A; Marzioni, M; Fernandez, M; Pereira, SP; Pohl, J; Poley, JW; Ponsioen, CY; Schramm, C; Swahn, F; Tringali, A; Hassan, C Role of endoscopy in primary sclerosing cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver (EASL) Clinical Guideline.
Endoscopy. 2017; 49(6):588-608 Doi: 10.1055/s-0043-107029 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Atanasov, G; Schierle, K; Hau, HM; Dietel, C; Krenzien, F; Brandl, A; Wiltberger, G; Englisch, JP; Robson, SC; Reutzel-Selke, A; Pascher, A; Jonas, S; Pratschke, J; Benzing, C; Schmelzle, M Prognostic Significance of Tumor Necrosis in Hilar Cholangiocarcinoma.
Ann Surg Oncol. 2017; 24(2): 518-525. Doi: 10.1245/s10434-016-5472-0
Web of Science PubMed FullText FullText_MUG

 

Dengler, M; Staufer, K; Huber, H; Stauber, R; Bantel, H; Weiss, KH; Starlinger, P; Pock, H; Klöters-Plachky, P; Gotthardt, DN; Rauch, P; Lackner, C; Stift, J; Brostjan, C; Gruenberger, T; Kumada, T; Toyoda, H; Tada, T; Weiss, TS; Trauner, M; Mikulits, W Soluble Axl is an accurate biomarker of cirrhosis and hepatocellular carcinoma development: results from a large scale multicenter analysis.
Oncotarget. 2017; 8(28):46234-46248 Doi: 10.18632/oncotarget.17598 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Gkika, E; Hallauer, L; Kirste, S; Adebahr, S; Bartl, N; Neeff, HP; Fritsch, R; Brass, V; Nestle, U; Grosu, AL; Brunner, TB Stereotactic body radiotherapy (SBRT) for locally advanced intrahepatic and extrahepatic cholangiocarcinoma.
BMC Cancer. 2017; 17(1):781 Doi: 10.1186/s12885-017-3788-1 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Jendrek, ST; Gotthardt, D; Nitzsche, T; Widmann, L; Korf, T; Michaels, MA; Weiss, KH; Liaskou, E; Vesterhus, M; Karlsen, TH; Mindorf, S; Schemmer, P; Bär, F; Teegen, B; Schröder, T; Ehlers, M; Hammers, CM; Komorowski, L; Lehnert, H; Fellermann, K; Derer, S; Hov, JR; Sina, C Anti-GP2 IgA autoantibodies are associated with poor survival and cholangiocarcinoma in primary sclerosing cholangitis.
Gut. 2017; 66(1):137-144 Doi: 10.1136/gutjnl-2016-311739
Web of Science PubMed FullText FullText_MUG

 

Račkauskas, R; Zhou, D; Ūselis, S; Strupas, K; Herr, I; Schemmer, P Sulforaphane sensitizes human cholangiocarcinoma to cisplatin via the downregulation of anti-apoptotic proteins.
Oncol Rep. 2017; 37(6):3660-3666 Doi: 10.3892/or.2017.5622 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2016

Atanasov, G; Hau, HM; Dietel, C; Benzing, C; Krenzien, F; Brandl, A; Englisch, JP; Wiltberger, G; Schierle, K; Robson, SC; Reutzel-Selke, A; Jonas, S; Pascher, A; Pratschke, J; Schmelzle, M Prognostic significance of TIE2-expressing monocytes in hilar cholangiocarcinoma.
J Surg Oncol. 2016; 114(1): 91-8. Doi: 10.1002/jso.24249
Web of Science PubMed FullText FullText_MUG

 

Brunner, TB; Seufferlein, T Radiation therapy in cholangiocellular carcinomas.
Best Pract Res Clin Gastroenterol. 2016; 30(4):593-602 Doi: 10.1016/j.bpg.2016.08.003
Web of Science PubMed FullText FullText_MUG

 

He, JC; Yao, W; Wang, JM; Schemmer, P; Yang, Y; Liu, Y; Qian, YW; Qi, WP; Zhang, J; Shen, Q; Yang, T TACC3 overexpression in cholangiocarcinoma correlates with poor prognosis and is a potential anti-cancer molecular drug target for HDAC inhibitors.
Oncotarget. 2016; 7(46):75441-75456 Doi: 10.18632/oncotarget.12254 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Wiltberger, G; Krenzien, F; Benzing, C; Atanasov, G; Klein, F; Hau, HM; Feldbrügge, L; Pratschke, J; Schmelzle, M; Jonas, S Prognostic Accuracy of the Seventh Edition of the TNM Classification Compared with the Fifth and Sixth Edition for Distal Cholangiocarcinoma.
Ann Surg Oncol. 2016; 23(4): 1320-6. Doi: 10.1245/s10434-015-4999-9
Web of Science PubMed FullText FullText_MUG

 

Yang, Y; Liu, Y; He, JC; Wang, JM; Schemmer, P; Ma, CQ; Qian, YW; Yao, W; Zhang, J; Qi, WP; Fu, Y; Feng, W; Yang, T 14-3-3ζ and aPKC-ι synergistically facilitate epithelial-mesenchymal transition of cholangiocarcinoma via GSK-3β/Snail signaling pathway.
Oncotarget. 2016; 7(34):55191-55210 Doi: 10.18632/oncotarget.10483 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2015

Atanasov, G; Hau, HM; Dietel, C; Benzing, C; Krenzien, F; Brandl, A; Wiltberger, G; Matia, I; Prager, I; Schierle, K; Robson, SC; Reutzel-Selke, A; Pratschke, J; Schmelzle, M; Jonas, S Prognostic significance of macrophage invasion in hilar cholangiocarcinoma.
BMC Cancer. 2015; 15: 790 Doi: 10.1186/s12885-015-1795-7 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Bektas, H; Yeyrek, C; Kleine, M; Vondran, FW; Timrott, K; Schweitzer, N; Vogel, A; Jäger, MD; Schrem, H; Klempnauer, J; Kousoulas, L Surgical treatment for intrahepatic cholangiocarcinoma in Europe: a single center experience.
J Hepatobiliary Pancreat Sci. 2015; 22(2): 131-137. Doi: 10.1002/jhbp.158 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Hoffmann, K; Luible, S; Goeppert, B; Weiss, KH; Hinz, U; Büchler, MW; Schemmer, P Impact of portal vein resection on oncologic long-term outcome in patients with hilar cholangiocarcinoma.
Surgery. 2015; 158(5):1252-1260 Doi: 10.1016/j.surg.2015.04.032
Web of Science PubMed FullText FullText_MUG

 

Juntermanns, B; Sydor, S; Kaiser, GM; Jaradat, D; Mertens, JC; Sotiropoulos, GC; Swoboda, S; Neuhaus, JP; Meng, W; Mathé, Z; Baba, HA; Canbay, A; Paul, A; Fingas, CD Polo-like kinase 3 is associated with improved overall survival in cholangiocarcinoma.
Liver Int. 2015; 35(11):2448-2457 Doi: 10.1111/liv.12839
Web of Science PubMed FullText FullText_MUG

 

Kremer, M; Manzini, G; Hristov, B; Polychronidis, G; Mokry, T; Sommer, CM; Mehrabi, A; Weitz, J; Büchler, MW; Schemmer, P Impact of Neoadjuvant Chemotherapy on Hypertrophy of the Future Liver Remnant after Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy.
J Am Coll Surg. 2015; 221(3):717-728 Doi: 10.1016/j.jamcollsurg.2015.05.017
Web of Science PubMed FullText FullText_MUG

 

Seehofer, D; Brunner, TB; Wege, H Current therapy concepts for local cholangiocarcinoma
ONKOLOGE. 2015; 21(11): 1054-1063. Doi: 10.1007/s00761-015-2931-3
Web of Science FullText FullText_MUG

 

2014

Atanasov, G; Schmelzle, M; Thelen, A; Wiltberger, G; Hau, HM; Krenzien, F; Petersen, TO; Moche, M; Jonas, S Selective hypertrophy of the lobus caudatus as a novel approach enabling extended right hepatectomy in the presence of a non-perfused left lateral liver lobe.
Clin J Gastroenterol. 2014; 7(4): 370-5. Doi: 10.1007/s12328-014-0511-5 (- Case Report) [OPEN ACCESS]
PubMed FullText FullText_MUG

 

Dolak, W; Schreiber, F; Schwaighofer, H; Gschwantler, M; Plieschnegger, W; Ziachehabi, A; Mayer, A; Kramer, L; Kopecky, A; Schrutka-Kölbl, C; Wolkersdörfer, G; Madl, C; Berr, F; Trauner, M; Püspök, A, , Austrian, Biliary, RFA, Study, Group Endoscopic radiofrequency ablation for malignant biliary obstruction: a nationwide retrospective study of 84 consecutive applications.
Surg Endosc. 2014; 28(3):854-60 Doi: 10.1007/s00464-013-3232-9
Web of Science PubMed FullText FullText_MUG

 

Klose, J; Klose, MA; Metz, C; Lehner, F; Manns, MP; Klempnauer, J; Hoppe, N; Schrem, H; Kaltenborn, A Outcome stagnation of liver transplantation for primary sclerosing cholangitis in the Model for End-Stage Liver Disease era.
Langenbecks Arch Surg. 2014; 399(8): 1021-1029. Doi: 10.1007/s00423-014-1214-6 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Müller, SA; Mehrabi, A; Rahbari, NN; Warschkow, R; Elbers, H; Leowardi, C; Fonouni, H; Tarantino, I; Schemmer, P; Schmied, BM; Büchler, MW Allogeneic blood transfusion does not affect outcome after curative resection for advanced cholangiocarcinoma.
Ann Surg Oncol. 2014; 21(1):155-164 Doi: 10.1245/s10434-013-3226-9
Web of Science PubMed FullText FullText_MUG

 

Pinter, M; Hucke, F; Zielonke, N; Waldhör, T; Trauner, M; Peck-Radosavljevic, M; Sieghart, W Incidence and mortality trends for biliary tract cancers in Austria.
Liver Int. 2014; 34(7):1102-1108 Doi: 10.1111/liv.12325
Web of Science PubMed FullText FullText_MUG

 

Weitere 50 Treffer anzeigen

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum